Number of items: 1.
Collapse authors list.
Godman, Brian ORCID: 0000-0001-6539-6972, McCabe, Holly, D Leong, Trudy ORCID: 0000-0003-2687-7751, Mueller, Debjani, Martin, Antony P ORCID: 0000-0003-4383-6038, Hoxha, Iris, Mwita, Julius C ORCID: 0000-0002-5947-3684, Rwegerera, Godfrey Mutashambara ORCID: 0000-0002-5896-6065, Massele, Amos, Costa, Juliana de Oliveira ORCID: 0000-0002-8355-023X et al (show 45 more authors) , do Nascimento, Renata Cristina Rezende Macedo ORCID: 0000-0001-7756-2157, Lemos, Livia Lovato Pires de ORCID: 0000-0002-8921-515X, Tachkov, Konstantin ORCID: 0000-0002-3961-7556, Milushewa, Petya, Patrick, Okwen, Niba, Loveline Lum, Laius, Ott, Sefah, Israel ORCID: 0000-0001-6963-0519, Abdulsalim, Suhaj ORCID: 0000-0002-6450-9848, Soleymani, Fatemeh ORCID: 0000-0002-6920-8796, Guantai, Anastasia N, Achieng, Loice ORCID: 0000-0003-4632-8792, Oluka, Margaret, Jakupi, Arianit, Logviss, Konstantīns, Hassali, Mohamed Azmi ORCID: 0000-0001-9575-403X, Kibuule, Dan ORCID: 0000-0002-6908-2177, Kalemeera, Francis ORCID: 0000-0002-4320-5087, Mubita, Mwangana, Fadare, Joseph ORCID: 0000-0002-5641-1402, Ogunleye, Olayinka O ORCID: 0000-0002-8921-1909, Saleem, Zikria ORCID: 0000-0003-3202-6347, Hussain, Shazhad, Bochenek, Tomasz ORCID: 0000-0001-9915-7267, Mardare, Ileana ORCID: 0000-0002-4725-9808, Alrasheedy, Alian A ORCID: 0000-0003-3617-7425, Furst, Jurij, Tomek, Dominik, Markovic-Pekovic, Vanda ORCID: 0000-0001-8963-5720, Rampamba, Enos M ORCID: 0000-0002-3492-9104, Alfadl, Abubakr ORCID: 0000-0002-3014-1408, Amu, Adefolarin A, Matsebula, Zinhle, Phuong, Thuy Nguyen Thi ORCID: 0000-0001-7939-5276, Thanh, Binh Nguyen, Chichonyi Kalungia, Aubrey ORCID: 0000-0003-2554-1236, Zaranyika, Trust ORCID: 0000-0003-4363-7709, Masuka, Nyasha ORCID: 0000-0003-4653-8626, Olaru, Ioana D ORCID: 0000-0003-3392-9257, Wale, Janney, Hill, Ruaraidh, Kurdi, Amanj ORCID: 0000-0001-5036-1988, Timoney, Angela, Campbell, Stephen ORCID: 0000-0002-2328-4136 and Meyer, Johanna C ORCID: 0000-0003-0462-5713
(2020)
Fixed dose drug combinations - are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries.
Expert review of pharmacoeconomics & outcomes research.
1 - 26.
This list was generated on Tue Apr 14 22:30:40 2020 BST.